Skip to content

Comparison of the 5-HT3 receptors antagonists effect for preventing postoperative nausea and vomiting in morbid obese patients undergoing laparoscopic bariatric surgery

Comparison of the 5-HT3 receptors antagonists effect for preventing postoperative nausea and vomiting in morbid obese patients undergoing laparoscopic bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003873
Enrollment
140
Registered
2019-04-30
Start date
2013-01-16
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In 140 patients with bariatric surgery , they randomly enroll 4 groups and each patients receive antiemetics 30 minutes before the end of surgery. Each group consists of 35 patients. Control gr

Sponsors

Soon Chun Hyang University Hospital Seoul
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: morbid obese patients with undergoing laparoscopic bariatric surgery (sleeve gastrectomy, roun-en–y bypass) between 19-65 years old and ASA(American Society of Anesthesiologists) physical status class I,II

Exclusion criteria

Exclusion criteria: administration of anti-emetics or steroids 24hr prior to surgery, pregnancy, allergy history about the drugs

Design outcomes

Primary

MeasureTime frame
PONV indicence during 24 hours after the bariatric surgery

Secondary

MeasureTime frame
PONV incidence bariatric surgery after 6 hours and after 6-24 hour, the use of rescue antiemetics, side effects

Countries

Korea, Republic of

Contacts

Public Contacthearim chun

Soon Chun Hyang University Hospital Seoul

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026